Plant ID: NPO5681
Plant Latin Name: Acorus gramineus
Taxonomy Genus: Acorus
Taxonomy Family: Acoraceae
NCBI TaxonomyDB:
55184
Plant-of-the-World-Online:
n.a.
Anodyne; Antibacterial; Antifungal; Antiperiodic; Antirheumatic; Antispasmodic; Aromatic; Cardiac; Carminative; Diaphoretic; Diuretic; Emmenagogue; Expectorant; Febrifuge; Parasiticide; Sedative; Stimulant; Stomachic; Tonic; Vermifuge
India; South Korea; China; Thailand
ADORA3; PTAFR; FFAR1; FFAR4; | |
GRM1; GRM8; | |
BLM; PKM; HSD17B10; ALOX15; | |
GRIA4; GRIA2; GRIK3; GRIK5; GRIK1; | |
GABRR1; | |
MAPK1; | |
TP53; | |
KMT2A; | |
SLC1A1; | |
LMNA; FABP3; FABP4; MAPT; | |
SMN1;SMN2; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Enzyme_unclassified | BLM | Bloom syndrome protein | P54132 | CHEMBL1293237 |
Enzyme_unclassified | PKM | Pyruvate kinase isozymes M1/M2 | P14618 | CHEMBL1075189 |
Enzyme_unclassified | HSD17B10 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | CHEMBL4159 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
GABA-A receptor | GABRR1 | GABA receptor rho-1 subunit | P24046 | CHEMBL3561 |
Ionotropic glutamate receptor | GRIA4 | Glutamate receptor ionotropic, AMPA 4 | P48058 | CHEMBL3190 |
Ionotropic glutamate receptor | GRIA2 | Glutamate receptor ionotropic, AMPA 2 | P42262 | CHEMBL4016 |
Ionotropic glutamate receptor | GRIK3 | Glutamate receptor ionotropic kainate 3 | Q13003 | CHEMBL3684 |
Ionotropic glutamate receptor | GRIK5 | Glutamate receptor ionotropic kainate 5 | Q16478 | CHEMBL2675 |
Ionotropic glutamate receptor | GRIK1 | Glutamate receptor ionotropic kainate 1 | P39086 | CHEMBL1918 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Plant homeodomain | KMT2A | Histone-lysine N-methyltransferase MLL | Q03164 | CHEMBL1293299 |
Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
SLC superfamily of solute carriers | SLC1A1 | Excitatory amino acid transporter 3 | P43005 | CHEMBL2721 |
Small molecule receptor (family A GPCR) | ADORA3 | Adenosine A3 receptor | P0DMS8 | CHEMBL256 |
Small molecule receptor (family A GPCR) | PTAFR | Platelet activating factor receptor | P25105 | CHEMBL250 |
Small molecule receptor (family A GPCR) | FFAR1 | Free fatty acid receptor 1 | O14842 | CHEMBL4422 |
Small molecule receptor (family A GPCR) | FFAR4 | G-protein coupled receptor 120 | Q5NUL3 | CHEMBL5339 |
Small molecule receptor (family C GPCR) | GRM1 | Metabotropic glutamate receptor 1 | Q13255 | CHEMBL3772 |
Small molecule receptor (family C GPCR) | GRM8 | Metabotropic glutamate receptor 8 | O00222 | CHEMBL3228 |
Transcription Factor | TP53 | Cellular tumor antigen p53 | P04637 | CHEMBL4096 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Unclassified | FABP3 | Fatty acid binding protein muscle | P05413 | CHEMBL3344 |
Unclassified | FABP4 | Fatty acid binding protein adipocyte | P15090 | CHEMBL2083 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0005215; transporter activity | GO:0005234; extracellularly glutamate-gated ion channel activity | 3.372E-11 | 1.836E-07 | GRIA2, GRIA4, GRIK1, GRIK3, GRIK5 |
BP | GO:0009987; cellular process | GO:0035235; ionotropic glutamate receptor signaling pathway | 1.896E-10 | 8.255E-07 | GRIA2, GRIA4, GRIK1, GRIK3, GRIK5 |
MF | GO:0005215; transporter activity | GO:0015277; kainate selective glutamate receptor activity | 2.161E-08 | 2.774E-05 | GRIK1, GRIK3, GRIK5 |
BP | GO:0023052; signaling | GO:0060079; excitatory postsynaptic potential | 3.115E-08 | 3.230E-05 | GRIA2, GRIA4, GRIK1, GRIK3, GRIK5 |
BP | GO:0009987; cellular process | GO:0007196; adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway | 1.809E-07 | 1.203E-04 | GRIK3, GRM1, GRM8 |
MF | Unclassified; | GO:0004872; receptor activity | 2.361E-07 | 1.512E-04 | ADORA3, FFAR1, FFAR4, GABRR1, GRIA2, GRIA4, GRIK1, GRIK3, GRIK5, GRM1, GRM8, PTAFR |
CC | GO:0044456; synapse part | GO:0045211; postsynaptic membrane | 3.036E-07 | 1.836E-04 | GABRR1, GRIA2, GRIA4, GRIK1, GRIK3, GRIK5 |
CC | GO:0044464; cell part | GO:0043204; perikaryon | 4.079E-07 | 2.338E-04 | GRIK3, GRIK5, MAPK1, SMN1, SMN2 |
BP | GO:0023052; signaling | GO:0051966; regulation of synaptic transmission, glutamatergic | 1.116E-06 | 5.651E-04 | GRIK1, GRIK3, GRM1, GRM8 |
MF | GO:0005215; transporter activity | GO:0008381; mechanosensitive ion channel activity | 4.318E-06 | 1.881E-03 | GABRR1, GRIA2, GRIA4, GRIK1, GRIK3, GRIK5 |
MF | GO:0005488; binding | GO:0005504; fatty acid binding | 6.198E-06 | 2.595E-03 | FABP3, FABP4, FFAR4 |
CC | GO:0044464; cell part | GO:0042995; cell projection | 6.497E-06 | 2.669E-03 | GRIA2, GRIA4, GRIK3, GRIK5, GRM1, MAPK1, MAPT, PKM, SMN1, SMN2 |
MF | GO:0005215; transporter activity | GO:0004971; AMPA glutamate receptor activity | 1.044E-05 | 3.987E-03 | GRIA2, GRIA4 |
CC | GO:0044425; membrane part | GO:0008328; ionotropic glutamate receptor complex | 3.163E-05 | 9.699E-03 | GRIA2, GRIA4, GRIK5 |
BP | GO:0023052; signaling | GO:0023051; regulation of signaling | 3.315E-05 | 9.756E-03 | ALOX15, BLM, FFAR1, FFAR4, GRIK1, GRIK3, GRIK5, GRM1, GRM8, KMT2A, LMNA, MAPK1, MAPT, TP53 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09150 Organismal Systems | 09156 Nervous system | hsa04724 | Glutamatergic synapse | 1.327E-14 | 1.725E-12 | GRIA2, GRIK5, SLC1A1, GRM8, GRIK3, MAPK1, GRIK1, GRM1, GRIA4 |
09130 Environmental Information Processing | 09133 Signaling molecules and interaction | hsa04080 | Neuroactive ligand-receptor interaction | 9.649E-13 | 6.272E-11 | GRIA2, GABRR1, GRIK5, ADORA3, PTAFR, GRM8, GRIK3, GRIK1, GRM1, GRIA4 |
09150 Organismal Systems | 09156 Nervous system | hsa04723 | Retrograde endocannabinoid signaling | 1.797E-07 | 7.788E-06 | GRIA2, GABRR1, MAPK1, GRM1, GRIA4 |
09160 Human Diseases | 09164 Substance dependence | hsa05033 | Nicotine addiction | 1.866E-05 | 6.066E-04 | GRIA2, GABRR1, GRIA4 |
09150 Organismal Systems | 09156 Nervous system | hsa04730 | Long-term depression | 6.354E-05 | 1.642E-03 | GRIA2, MAPK1, GRM1 |
09150 Organismal Systems | 09156 Nervous system | hsa04720 | Long-term potentiation | 8.453E-05 | 1.642E-03 | GRIA2, MAPK1, GRM1 |
09160 Human Diseases | 09161 Cancers | hsa05230 | Central carbon metabolism in cancer | 8.841E-05 | 1.642E-03 | PKM, MAPK1, TP53 |
09150 Organismal Systems | 09159 Environmental adaptation | hsa04713 | Circadian entrainment | 2.494E-04 | 4.052E-03 | GRIA2, MAPK1, GRIA4 |
09140 Cellular Processes | 09143 Cell growth and death | hsa04210 | Apoptosis | 7.757E-04 | 9.118E-03 | LMNA, MAPK1, TP53 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04071 | Sphingolipid signaling pathway | 4.952E-04 | 7.152E-03 | ADORA3, MAPK1, TP53 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04072 | Phospholipase D signaling pathway | 8.417E-04 | 9.118E-03 | GRM8, MAPK1, GRM1 |
09160 Human Diseases | 09161 Cancers | hsa05216 | Thyroid cancer | 6.457E-04 | 8.394E-03 | MAPK1, TP53 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
J00-J99: Diseases of the respiratory system | Asthma | J45 | PTAFR; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Nerve injury | T14.4 | PTAFR; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Allergy | T78.4 | PTAFR; |
A00-B99: Certain infectious and parasitic diseases | Septic shock | A41.9 | PTAFR; |
H00-H59: Diseases of the eye and adnexa | Glaucoma | H40-H42 | ADORA3; |
G00-G99: Diseases of the nervous system G00-G99 | Epilepsy | G40 | GRIK1; |
A00-B99: Certain infectious and parasitic diseases | Malaria | B54 | ADORA3; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Toxicity | T36-T50, T51-T65 | TP53; |
H60-H95: Diseases of the ear and mastoid process | Hearing disorder | H90.5 | TP53; |
C00-D49: Neoplasms | Head and neck cancer | C07-C14, C32-C33 | TP53; |
C00-D49: Neoplasms | Hematological malignancies | C81-C86 | TP53; |
NA: NA | Hepatitis C virus infection | NA | ADORA3; |
H00-H59: Diseases of the eye and adnexa | Conjunctivitis | H10 | PTAFR; |
C00-D49: Neoplasms | Colorectal cancer | C18-C21 | TP53; |
D50-D89: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism | Thrombocytopenia | D69.6, P61.0 | PTAFR; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Huntington's disease | F02.2, G10 | GRM1; |
C00-D49: Neoplasms | Cancer | C00-C96 | ADORA3; MAPK1; TP53; |
C00-D49: Neoplasms | Acute myeloid leukemia | C92.0 | TP53; |
I00-I99: Diseases of the circulatory system | Thromboembolism | I80-I82 | PTAFR; |
I00-I99: Diseases of the circulatory system | Ischemia | I99.8 | ADORA3; |
I00-I99: Diseases of the circulatory system | Stroke | I61-I63, I80-I82 | PTAFR; |
I00-I99: Diseases of the circulatory system | Cardiac arrhythmias | I47-I49 | PTAFR; |
L00-L99: Diseases of the skin and subcutaneous tissue | Psoriasis | L40 | PTAFR; |
G00-G99: Diseases of the nervous system G00-G99 | Spinal muscular atrophy | G00-G99 | SMN1;SMN2; |
C00-D49: Neoplasms | Late-stage solid tumors | C00-C75, C7A, C7B, D10-D36, D3A | TP53; |
G00-G99: Diseases of the nervous system G00-G99 | Alzheimer disease | G30 | GRM1; MAPT; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Schizophrenia | F20 | GRM1; |
G00-G99: Diseases of the nervous system G00-G99 | Brain ischaemia | G45.9, I67.8 | PTAFR; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Alcohol use disorders | F10.2 | GRIK1; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Cognitive disorders | F01-F07, F04, F05, R41.3 | MAPT; |
I00-I99: Diseases of the circulatory system | Restenosis | I51.89 | MAPK1; |
I00-I99: Diseases of the circulatory system | Renal artery disease | I70.1 | TP53; |
G00-G99: Diseases of the nervous system G00-G99 | Pain | G64, G90.0, R52, G89 | GRM1; PTAFR; GRIK1; PKM; |
G00-G99: Diseases of the nervous system G00-G99 | Parkinson's disease | G20 | GRIA2; GRIA4; |
H00-H59: Diseases of the eye and adnexa | Ocular allergy | H00-H59 | PTAFR; |
G00-G99: Diseases of the nervous system G00-G99 | Central nervous system disease | G00-G99 | MAPT; |
I00-I99: Diseases of the circulatory system | Cerebral infarction | I63 | PTAFR; |
I00-I99: Diseases of the circulatory system | Cerebrovascular ischaemia | I61-I63 | ADORA3; |
C00-D49: Neoplasms | Oral cavity cancer | C00-C08 | TP53; |
E00-E89: Endocrine, nutritional and metabolic diseases | Non-insulin dependent diabetes | E11.9 | FFAR1; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | PTAFR; MAPK1; PKM; TP53; |
C00-D49: Neoplasms | Refractory renal cell carcinoma | C64 | PKM; |
G00-G99: Diseases of the nervous system G00-G99 | Neurodegenerative disease | G30-G32 | MAPT; |
G00-G99: Diseases of the nervous system G00-G99 | Neuropathic pain | G64, G90.0 | GRM1; GRIK1; |
I00-I99: Diseases of the circulatory system | Neurological disease | I21, I22, R52, R52.1-R52.2, R60.9, G89 | GRM1; GRIK1; |
C00-D49: Neoplasms | Inflammatory disease | C11, C44, K75.9, M00-M25 | PTAFR; |
C00-D49: Neoplasms | Hepatocellular carcinoma | C22.0 | ADORA3; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | FFAR1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetes | E23.2, N25.1 | FFAR1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Inflammation | E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, G89 | ADORA3; |
K00-K95: Diseases of the digestive system | Inflammatory bowel disease | K50, K51 | PTAFR; |